View |
|
DRP-14359
|
Captopril
|
None
|
25 mg
|
Tablet
|
ACE Inhibitor
|
Phil. United Pharma Corporation
|
Philippines
|
Initial
|
24 August 2023
|
24 August 2028
|
View |
|
DRP-14360
|
Captopril
|
Doctopril
|
25 mg
|
Tablet
|
ACE Inhibitor
|
Phil. United Pharma Corporation
|
Philippines
|
Initial
|
24 August 2023
|
24 August 2028
|
View |
|
DRP-14361
|
Captopril
|
Golcap
|
25 mg
|
Tablet
|
Ace Inhibitors
|
Phil. United Pharma Corporation
|
Philippines
|
Initial
|
24 August 2023
|
24 August 2028
|
View |
|
DRP-14351
|
Adapalene
|
Adadoc
|
1 mg/g (0.1% w/w)
|
Topical Gel
|
Anti-acne (Retinoid)
|
Rhydburg Pharmaceuticals Ltd.
|
India
|
Initial (Re-application)
|
24 August 2023
|
24 August 2028
|
View |
|
DRP-14352
|
Adapalene
|
Adabur
|
1 mg/g (0.1% w/w)
|
Topical Gel
|
Anti-acne (Retinoid)
|
Rhydburg Pharmaceuticals Ltd.
|
India
|
Initial (Re-application)
|
24 August 2023
|
24 August 2028
|
View |
|
DRP-14326
|
Dexamethasone
Sodium Phosphate
|
Ezydox
|
1mg/mL (0.1% w/v)
|
Sterile Ophthalmic Solution
|
Corticosteroid
|
Skymap Healthcare Pvt. Ltd.
|
India
|
Initial
|
24 August 2023
|
24 August 2028
|
View |
|
DRHR-2280
|
Mineral Oil
|
None
|
100% w/w
|
Oral Solution
|
Cathartic/Laxative
|
Sonneborn Refined Products
|
United States of America
|
Initial (Reapplication)
|
24 August 2023
|
24 August 2028
|
View |
|
DR-XY48857
|
Co-Amoxiclav
|
Spotclav Forte
|
457 mg/5 mL
|
Powder for Oral Suspension. Antibacterial (Penicillin-Beta-lactamase Inhibitor Combination)
|
Antibacterial
|
Sparsh Bio-Tech Pvt. Ltd.
|
India
|
Initial (Re-application)
|
24 August 2023
|
24 August 2028
|
View |
|
DRP-14338
|
Glycerin
|
Gvsoft
|
1.2 g
|
Rectal Suppository
|
Laxative
|
Bliss GVS Pharma Ltd. Unit II
|
India
|
Initial [OTC]
|
29 August 2023
|
29 August 2028
|
View |
|
DR-XY48858
|
Levodropropizine
|
Bronzine
|
30 mg/5 mL
|
Syrup
|
Cough Suppressant
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
30 August 2023
|
30 August 2028
|
View |
|
DRP-14398
|
Moxifloxacin (as hydrochloride)
|
Moxilee
|
400 mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolone)
|
Lee Pharma Limited
|
India
|
Initial
|
31 August 2023
|
31 August 2028
|
View |
|
DR-XY48863
|
Meropenem (as trihydrate)
|
Meroz
|
1g
|
Powder for Injection (I.V.)
|
Antibacterial (Carbapenem)
|
Dongkwang Pharm. Co., Ltd
|
Korea
|
Initial
|
31 August 2023
|
31 August 2028
|
View |
|
DRP-14379
|
Telmisartan
|
Telisolv
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
View |
|
DRP-14376
|
Sultamicillin tosilate
|
None
|
750 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
View |
|
DRP-14377
|
Sultamicillin tosilate
|
None
|
375 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
View |
|
DRP-14378
|
Telmisartan
|
Telisolv
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
View |
|
DRP-14380
|
Telmisartan
|
Telisolv
|
20 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
View |
|
DRP-14381
|
Telmisartan
|
TeliGen-80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
View |
|
DRP-14382
|
Telmisartan
|
TeliGen-40
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|
View |
|
DRP-14383
|
Telmisartan
|
TeliGen-20
|
20 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 August 2023
|
31 August 2028
|